Literature DB >> 27999049

Improving feedback of surveillance data on antimicrobial consumption, resistance and stewardship in England: putting the data at your Fingertips.

Alan P Johnson1, Berit Muller-Pebody1, Emma Budd1,2, Diane Ashiru-Oredope2, David Ladenheim2, Doris Hain3, Russell Hope1, Alex Bhattacharya1, Suzanne Elgohari1, Rebecca Guy1, Katherine Henderson1, Richard Puleston4, Graeme Rooney1,2, Simon Thelwall1, Edgar Wellington1, Theresa Lamagni1, Susan Hopkins2.   

Abstract

The provision of better access to and use of surveillance data is a key component of the UK 5 Year Antimicrobial Resistance (AMR) Strategy. Since April 2016, PHE has made data on practice (infection prevention and control; antimicrobial stewardship) and outcome (prevalence of AMR, antibiotic use and healthcare-associated infections) available through Fingertips, a publicly accessible web tool (https://fingertips.phe.org.uk/profile/amr-local-indicators). Fingertips provides access to a wide range of public health data presented as thematic profiles, with the above data being available through the 'AMR local indicators' profile. Local data on a range of indicators can be viewed at the level of National Health Service acute trusts, Clinical Commissioning Groups or general practitioner practices, all of which can be compared with the corresponding aggregate values for England to allow benchmarking. The data can be viewed in a range of formats including an overview showing counts and rates, interactive maps, spine charts and graphs that show temporal trends over a range of time scales or allow correlations between pairs of indicators. The aim of the AMR local indicators profile on Fingertips is to support the development of local action plans to optimize antibiotic prescribing and reduce AMR and healthcare-associated infections. Provision of access to relevant information in an easy to use format will help local stakeholders, including healthcare staff, commissioners, Directors of Public Health, academics and the public, to benchmark relevant local AMR data and to monitor the impact of local initiatives to tackle AMR over time.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27999049     DOI: 10.1093/jac/dkw536

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  Revisiting Florence Nightingale: International Year of the Nurse and Midwife 2020.

Authors:  Heather P Loveday
Journal:  J Infect Prev       Date:  2020-01-20

2.  Targets for the reduction of antibiotic use in humans in the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) partner countries.

Authors:  Fabio D'Atri; Jacqueline Arthur; Hege Salvesen Blix; Lauri A Hicks; Diamantis Plachouras; Dominique L Monnet
Journal:  Euro Surveill       Date:  2019-07

3.  Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project.

Authors:  Maria Diletta Pezzani; Fulvia Mazzaferri; Monica Compri; Liliana Galia; Nico T Mutters; Gunnar Kahlmeter; Theoklis E Zaoutis; Mitchell J Schwaber; Jesús Rodríguez-Baño; Stephan Harbarth; Evelina Tacconelli
Journal:  J Antimicrob Chemother       Date:  2020-12-06       Impact factor: 5.790

4.  Antimicrobial Consumption as a Key Component of Antimicrobial Stewardship Programs: a Meaningful Movement toward Evidence-based Antimicrobial Stewardship of Validated Outcome Measures.

Authors:  Young Kyung Yoon
Journal:  J Korean Med Sci       Date:  2020-12-07       Impact factor: 2.153

Review 5.  White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks.

Authors:  Fabiana Arieti; Siri Göpel; Marcella Sibani; Elena Carrara; Maria Diletta Pezzani; Rita Murri; Nico T Mutters; Lorena Lòpez-Cerero; Andreas Voss; Roberto Cauda; Evelina Tacconelli
Journal:  J Antimicrob Chemother       Date:  2020-12-06       Impact factor: 5.790

Review 6.  White Paper: Bridging the gap between human and animal surveillance data, antibiotic policy and stewardship in the hospital sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks.

Authors:  Maria Diletta Pezzani; Elena Carrara; Marcella Sibani; Elisabeth Presterl; Petra Gastmeier; Hanna Renk; Souha S Kanj; Thirumalaisamy P Velavan; Le Huu Song; Leonard Leibovici; Didem Torumkuney; Tomislav Kostyanev; Marc Mendelson; Evelina Tacconelli
Journal:  J Antimicrob Chemother       Date:  2020-12-06       Impact factor: 5.790

7.  A standardized methodology for the surveillance of antimicrobial prescribing linked to clinical indications in primary care.

Authors:  Sue Smith; Jeremy I Hawker; Gillian E Smith; Roger Morbey; Alan P Johnson; Douglas M Fleming; Laura Shallcross; Andrew C Hayward
Journal:  J Public Health (Oxf)       Date:  2018-09-01       Impact factor: 2.341

8.  Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study.

Authors:  Hanan H Balkhy; Aiman El-Saed; Ashraf El-Metwally; Yaseen M Arabi; Sameera M Aljohany; Muayed Al Zaibag; Salim Baharoon; Adel F Alothman
Journal:  Antimicrob Resist Infect Control       Date:  2018-12-21       Impact factor: 4.887

9.  Proxy indicators to estimate appropriateness of antibiotic prescriptions by general practitioners: a proof-of-concept cross-sectional study based on reimbursement data, north-eastern France 2017.

Authors:  Nathalie Thilly; Ouarda Pereira; Jeroen Schouten; Marlies Ejl Hulscher; Céline Pulcini
Journal:  Euro Surveill       Date:  2020-07

10.  Proxy indicators to estimate the appropriateness of medications prescribed by paediatricians in infectious diseases: a cross-sectional observational study based on reimbursement data.

Authors:  N Thilly; O Pereira; J Schouten; M E J L Hulscher; C Pulcini
Journal:  JAC Antimicrob Resist       Date:  2020-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.